Lenalidomide

Specifications

191732-72-6CAS Number

691-297-1EC Number

3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dioneIUPAC Name

C13H13N3O3Chemical Formula

259.26 g/molMolecular Weight

Lenalidomide; 191732-72-6; Revlimid; Revimid; 3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione; CC-5013; 2,6-Piperidinedione, 3-(4-amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-; CDC 501; CDC-501; 3-(4-Amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione; DTXSID8046664; Lenalidomida; NSC-747972; F0P408N6V4; 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline; SYP-1512; 3-(4-amino-1-oxo-2,3-dihydro-1H-isoindol-2-yl)piperidine-2,6-dione; DTXCID6026664; CHEBI:63791; 4-amino-2-(6-hydroxy-2-oxo-2,3,4,5-tetrahydropyridin-3-yl)-2,3-dihydro-1H-isoindol-1-one; CC5013; IMiD3 cpd; lenalidomidum; RefChem:5941; L04AX04; NSC703813; 691-297-1; Lenalidomide (CC-5013); MFCD07772307; 3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione; CC 5013; Lenadoamide; C13H13N3O3; Revlimid (TN); 3-(4-amino-1,3-dihydro-1-oxo-2h-isoindol-2-yl)-2,6-piperidinedione; s1029; NCGC00167491-01; Lenalidomide [USAN]; 3-(4-Amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione; CAS-191732-72-6; Lenalidomide?; UNII-F0P408N6V4; Lenalidomide [USAN:INN:BAN]; Revimid;; ENMD 0997; ENMD-0997; HSDB 8220; IMID-5013; CDC-5013; ALBB-015321; Lenalidomide (Standard); LENALIDOMIDE [MI]; LENALIDOMIDE [INN]; LENALIDOMIDE [JAN]; CHEMBL848; Revlimid (TN) (Celgene); CC-5013 (Lenalidomide); LENALIDOMIDE [VANDF]; SCHEMBL32978; LENALIDOMIDE [MART.]; MLS003899194; LENALIDOMIDE [WHO-DD]; GTPL7331; Lenalidomide (JAN/USAN/INN); orb1225810; orb1307920; LENALIDOMIDE [EMA EPAR]; 3-(4-amino-1-oxo-isoindolin-2-yl)piperidine-2,6-dione; SCHEMBL26646478; SCHEMBL29414335; BDBM65454; HY-A0003R; Lenalidomide - Bio-X trade mark; 3-(7-Amino-3-oxo-1H-isoindol-2-yl)-piperidine-2,6-dione; HMS3654G07; HMS3674C05; HMS5079I05; LENALIDOMIDE [ORANGE BOOK]; CIA27191; HY-A0003; MSK10368; Revlimid, Lenalidomide, CC-5013; Tox21_112492; AC-914; EBC-11297; NSC747972; STK639603; 2,6-Piperidinedione, 3-(4-amino-1,3-dihydro-1-oxo-2H- isoindol-2-yl)-; AKOS005146276; AKOS005174869; Tox21_112492_1; CCG-264781; CS-0125; DB00480; FL24864; KS-1207; NSC 747972; SB66166; NCGC00167491-02; NCGC00167491-03; NCGC00167491-04; NCGC00167491-09; NCGC01443006-01; BL164614; BP-27972; SMR002529986; SY047646; L1852; NS00003666; SW218084-2; D04687; EN300-118706; AB01273975-01; AB01273975-02; AB01273975_03; F078933; Q425681; SR-01000883999; SR-01000883999-1; 1-Oxo-4-amino-2-(2,6-dioxopiperidin-3-yl)isoindole; BRD-A17883755-001-06-1; 3-(4-Amino-1-oxo-2-isoindolinyl)piperidine-2,6-dione; Z1515385074; 2, 3-(4-amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-; (R,S)-3-(4-Amino-1-oxo-3H-isoindol-2-yl)piperidine-2,6-dione; 3-(4-amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)-2,6-dioxopiperidine; Lenalidomide Hemihydrate; Lenalidomide Hydrate; Anhydrous LenalidomideSynonyms